Pharmena S.A. PHR.WA Stock
Pharmena S.A. Price Chart
Pharmena S.A. PHR.WA Financial and Trading Overview
| Pharmena S.A. stock price | 7.2 PLN |
| Previous Close | 7.2 PLN |
| Open | 7.18 PLN |
| Bid | 6.88 PLN x N/A |
| Ask | 7.16 PLN x N/A |
| Day's Range | 6.58 - 7.18 PLN |
| 52 Week Range | 4.94 - 7.6 PLN |
| Volume | 133 PLN |
| Avg. Volume | 1.66K PLN |
| Market Cap | 79.75M PLN |
| Beta (5Y Monthly) | 0.775 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 2.6 PLN |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | August 3, 2016 |
| 1y Target Est | N/A |
PHR.WA Valuation Measures
| Enterprise Value | 88.34M PLN |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 4.608301 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 5.105 |
| Enterprise Value/EBITDA | -67.384 |
Trading Information
Pharmena S.A. Stock Price History
| Beta (5Y Monthly) | 0.775 |
| 52-Week Change | 20.40% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 7.6 PLN |
| 52 Week Low | 4.94 PLN |
| 50-Day Moving Average | 6.91 PLN |
| 200-Day Moving Average | 6.08 PLN |
PHR.WA Share Statistics
| Avg. Volume (3 month) | 1.66K PLN |
| Avg. Daily Volume (10-Days) | 664 PLN |
| Shares Outstanding | 11.14M |
| Float | 3.12M |
| Short Ratio | N/A |
| % Held by Insiders | 71.94% |
| % Held by Institutions | 4.44% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2021 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2022 |
Profitability
| Profit Margin | -12.99% |
| Operating Margin (ttm) | -8.66% |
| Gross Margin | 55.52% |
| EBITDA Margin | -7.57% |
Management Effectiveness
| Return on Assets (ttm) | -7.50% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | 17.31M PLN |
| Revenue Per Share (ttm) | 1.55 PLN |
| Quarterly Revenue Growth (yoy) | 30.69% |
| Gross Profit (ttm) | 8.25M PLN |
| EBITDA | -1311000 PLN |
| Net Income Avi to Common (ttm) | -2249000 PLN |
| Diluted EPS (ttm) | -0.14 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 1.49M PLN |
| Total Cash Per Share (mrq) | 0.13 PLN |
| Total Debt (mrq) | 12.16M PLN |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.642 |
| Book Value Per Share (mrq) | -0.593 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 1.21M PLN |
| Levered Free Cash Flow (ttm) | -101625 PLN |
Profile of Pharmena S.A.
| Country | Poland |
| State | N/A |
| City | Lódz |
| Address | ul. Wólczanska 178 |
| ZIP | 90-530 |
| Phone | 48 422 91 33 70 |
| Website | https://www.pharmena.eu |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 24 |
Pharmena S.A., a biotechnology company, manufactures and sells active ingredients in various areas of medicines in Poland and internationally. The company offers dermatological cosmetics, including skin, hair, and nail care products, as well as dietary supplement for atherosclerosis prophylaxis. It offers its products under the Menavitin, Dermena, Allerco, and Thermi names. The company is developing 1-MNA, an anti-atherosclerosis drug which is under phase II clinical trial. Pharmena S.A. was founded in 2002 and is based in Lódz, Poland. Pharmena S.A. is a subsidiary of Pelion S.A.
Q&A For Pharmena S.A. Stock
What is a current PHR.WA stock price?
Pharmena S.A. PHR.WA stock price today per share is 7.2 PLN.
How to purchase Pharmena S.A. stock?
You can buy PHR.WA shares on the Warsaw exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Pharmena S.A.?
The stock symbol or ticker of Pharmena S.A. is PHR.WA.
Which industry does the Pharmena S.A. company belong to?
The Pharmena S.A. industry is Biotechnology.
How many shares does Pharmena S.A. have in circulation?
The max supply of Pharmena S.A. shares is 11.14M.
What is Pharmena S.A. Price to Earnings Ratio (PE Ratio)?
Pharmena S.A. PE Ratio is 2.76923080 now.
What was Pharmena S.A. earnings per share over the trailing 12 months (TTM)?
Pharmena S.A. EPS is 2.6 PLN over the trailing 12 months.
Which sector does the Pharmena S.A. company belong to?
The Pharmena S.A. sector is Healthcare.